ARTICLE | Company News
Kotobuki, Shionogi in deal for cholesterol absorption inhibitor
October 2, 2012 1:29 AM UTC
Kotobuki Pharmaceutical Co. (Tokyo, Japan) granted Shionogi & Co. Ltd. (Osaka, Japan) worldwide rights to develop and commercialize cholesterol absorption inhibitor KT6-971. Kotobuki will receive an u...